Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Ocular Therapeut (OCUL)

Ocular Therapeut (OCUL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 400,764
  • Shares Outstanding, K 53,364
  • Annual Sales, $ 4,230 K
  • Annual Income, $ -86,370 K
  • 60-Month Beta 1.64
  • Price/Sales 94.81
  • Price/Cash Flow N/A
  • Price/Book N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate -0.33
  • Number of Estimates 4
  • High Estimate -0.29
  • Low Estimate -0.35
  • Prior Year -0.57
  • Growth Rate Est. (year over year) +42.11%

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.02 +6.98%
on 06/11/20
9.24 -18.72%
on 06/25/20
-0.21 (-2.78%)
since 06/08/20
3-Month
4.76 +57.77%
on 04/22/20
9.24 -18.72%
on 06/25/20
+2.27 (+43.32%)
since 04/08/20
52-Week
2.46 +205.28%
on 11/12/19
9.24 -18.72%
on 06/25/20
+2.28 (+43.59%)
since 07/08/19

Most Recent Stories

More News
Ocular Therapeutix(TM) to Hold Virtual 2020 Annual Meeting Of Stockholders

Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today...

OCUL : 7.51 (unch)
Ocular Therapeutix(TM) to Present Data at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting

Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, announced...

OCUL : 7.51 (unch)
Glaucoma Drugs Market Opportunities, Demands and Growth Revenue by 2025 | Brandessence Market Research Report

AERI : 13.41 (+0.68%)
AGN : 193.02 (+0.02%)
CANF : 1.8100 (-4.23%)
ITEK : 3.04 (-5.00%)
MRK : 77.92 (-1.02%)
NMUS : 0.6500 (-9.52%)
NVS : 88.12 (+0.36%)
OCAT : 8.47 (+0.12%)
OCUL : 7.51 (unch)
OHRP : 5.39 (+30.19%)
PRGO : 54.93 (-0.49%)
PFE : 33.75 (-0.82%)
SNPHF : 17.7000 (-4.84%)
SCMP : 18.05 (+0.28%)
TEVA : 11.40 (+1.69%)
VRX.TO : 30.80 (-3.33%)
Ocular Therapeutix(TM) to Present at the 2020 Raymond James Human Health Innovation Conference

Ocular Therapeutix, Inc. (NASDAQ:OCUL) a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced...

OCUL : 7.51 (unch)
Ocular Therapeutix(TM) to Present at the Jefferies Virtual Healthcare Conference

Ocular Therapeutix, Inc. (NASDAQ:OCUL) a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced...

OCUL : 7.51 (unch)
Find Stocks Under $10 to Buy Amid Coronavirus Economic Reopening

Find Stocks Under $10 to Buy Amid Coronavirus Economic Reopening

OCUL : 7.51 (unch)
GLUU : 9.75 (+2.31%)
FRO : 7.40 (+4.23%)
CRON : 6.19 (-1.28%)
AUY : 5.56 (+0.54%)
Ocular Therapeutix(TM) Announces Pricing of Public Offering of Common Stock

Ocular Therapeutix(TM), Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today...

OCUL : 7.51 (unch)
Ocular Therapeutix(TM) Announces Proposed Public Offering of Common Stock

Ocular Therapeutix(TM), Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today...

OCUL : 7.51 (unch)
Ocular Therapeut Up 23.5% Since SmarTrend Uptrend Call (OCUL)

SmarTrend identified an Uptrend for Ocular Therapeut (NASDAQ:OCUL) on April 13th, 2020 at $5.57. In approximately 1 month, Ocular Therapeut has returned 23.54% as of today's recent price of $6.88.

OCUL : 7.51 (unch)
Thinking about buying stock in VBI Vaccines, Aphria, Ocular Therapeutix, New Age Beverages, or General Electric?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for VBIV, APHA, OCUL, NBEV, and GE.

APHA : 4.31 (-0.46%)
GE : 6.86 (+1.48%)
NBEV : 1.5300 (-0.65%)
OCUL : 7.51 (unch)
VBIV : 3.95 (+17.56%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade OCUL with:

Business Summary

Ocular Therapeutix, Inc. is a biopharmaceutical company. It is focused on the development and commercialization of ophthalmic therapeutic products using its proprietary hydrogel technology to address unmet or underserved needs in ophthalmology. The Company develops and markets eye care products. Ocular...

See More

Key Turning Points

2nd Resistance Point 7.96
1st Resistance Point 7.73
Last Price 7.51
1st Support Level 7.37
2nd Support Level 7.24

See More

52-Week High 9.24
Last Price 7.51
Fibonacci 61.8% 6.65
Fibonacci 50% 5.85
Fibonacci 38.2% 5.05
52-Week Low 2.46

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar